A new study from Mass General Brigham suggests that a simple blood test could help detect the risk of Alzheimer’s disease much earlier than doctors once believed.
This discovery could make it easier to identify people at risk before memory problems even begin.
Alzheimer’s disease is a brain condition that slowly damages memory and thinking skills. It is the most common cause of dementia in older adults. For many years, scientists have known that changes in the brain begin long before symptoms appear.
One of the earliest signs is the buildup of a protein called amyloid, which forms sticky plaques in the brain. Doctors usually detect this using special brain scans called PET scans, but these tests are expensive and not easy to access.
In this new research, scientists focused on a substance in the blood called pTau217. This substance is linked to another protein called tau, which forms harmful tangles inside brain cells in people with Alzheimer’s disease. When these tangles build up, they disrupt how brain cells work and eventually lead to cell death.
The study was published in Nature Communications and followed 317 older adults who did not have any memory problems at the start. These participants were part of the Harvard Aging Brain Study and were observed for about eight years. During this time, they had regular blood tests, brain scans, and memory assessments.
The researchers wanted to see whether levels of pTau217 in the blood could predict future changes in the brain and thinking ability. What they found was striking. People with higher levels of pTau217 were more likely to develop signs of Alzheimer’s disease later on. In many cases, changes in pTau217 appeared before any problems could be seen on brain scans.
This means the blood test could detect early signs of the disease even before traditional methods. On the other hand, people with low levels of pTau217 were unlikely to develop amyloid buildup over many years. This suggests the test could also help reassure people who are at lower risk.
The findings are important because they show that a simple blood test might one day replace more complex and costly procedures. In recent years, the U.S. Food and Drug Administration has already approved the first blood test for Alzheimer’s disease, showing that this approach is becoming more realistic.
The lead researcher, Dr. Hyun-Sik Yang, explained that scientists used to believe PET scans were the earliest way to detect Alzheimer’s changes. However, this study suggests that blood markers like pTau217 may appear even earlier, giving doctors a longer window to act.
Although this test is not yet ready for routine use, it could play a major role in the future. It may help doctors identify people who could benefit from early treatment or lifestyle changes. It could also make it easier to recruit the right participants for clinical trials aimed at preventing Alzheimer’s disease.
Overall, this study offers hope for earlier and simpler detection of Alzheimer’s disease. However, there are still some limitations.
The study focused on a specific group of older adults, so more research is needed to confirm the findings in larger and more diverse populations. In addition, while the test can predict risk, it does not guarantee that someone will develop the disease.
Even so, the results are very promising. Being able to detect Alzheimer’s risk earlier could allow people to take action sooner, whether through medical care, lifestyle changes, or future treatments. This could improve quality of life and possibly delay the onset of symptoms.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease , and new non-drug treatment that could help prevent Alzheimer’s.
For more health information, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
Source: Mass General Brigham.
